Skip to content

Design, implementation, and evaluation of an educational mobile application for the management of chemotherapy side effects in patients with leukemia

Design, implementation, and evaluation of an educational mobile application for the management of chemotherapy side effects in patients with leukemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230816059164N3
Enrollment
112
Registered
2024-08-23
Start date
2024-09-22
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia. Plasma cell leukemia

Interventions

Intervention 1: Intervention group: The intervention group will receive the symptom management training application. The educational content of this application will be approved by experts before bein

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Willingness of the client to participate in the research Having access to a mobile phone with Android operating system Be able to read and write and to work with a mobile phone The client should be only undergoing chemotherapy and has not received other methods such as bone marrow transplant The client should have completed a maximum of three chemotherapy courses

Exclusion criteria

Exclusion criteria: The client's unwillingness to continue cooperation in each of the stages of the study It becomes impossible for the client to use the educational application for any reason The patient's chemotherapy course has been stopped Patient's death

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Fatigue. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Nausea. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Depression. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Anxiety. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Drowsiness. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Appetite. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Feeling of Well-Being. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Shortness of Breath. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mehdi Rajabi

Tehran University of Medical Sciences

mmehdirajabi1379@gmail.com+98 21 6105 4424

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026